and it reduces the frequency and severity of ventricular arrhythmias in patients with implanted cardioverter-defibrillators
or in combination with Docetaxel (15 mg/kg) or Irinotecan (25 mg/kg) to significantly reduce the tumor volume
Expert Opinion on Investigational Drugs
InChi: InChI=1S/C111H188N42O24S2/c1-59(2)52-76-97(168)148-79(54-62-22-8-7-9-23-62)99(170)151-86(61(5)6)102(173)149-78(55-63-34-36-64(154)37-35-63)98(169)150-80(100(171)147-77(53-60(3)4)96(167)146-76)58-179-178-57-65(114)87(158)135-56-85(157)136-66(26-14-44-129-106(117)118)88(159)137-67(24-10-12-42-112)89(160)138-68(25-11-13-43-113)90(161)139-69(27-15-45-130-107(119)120)91(162)140-71(29-17-47-132-109(123)124)93(164)143-73(38-40-83(115)155)95(166)142-70(28-16-46-131-108(121)122)92(163)141-72(30-18-48-133-110(125)126)94(165)144-74(31-19-49-134-111(127)128)103(174)153-51-21-33-82(153)104(175)152-50-20-32-81(152)101(172)145-75(105(176)177)39-41-84(116)156/h7-9
Brivanib is the hydrolyzed form of Brivanib alaninate
TH34 Catalog No.:M13549-10 and it reduces the frequencyTH34 is a HDAC inhibitor that shows pronounced selectivity for HDACs 6, 8 and 10 over HDACs 1, 2 and 3. In a NanoBRET assay, TH34 strongly binds HDAC6, 8 and 10 with low micromolar IC50 concentrations (HDAC6: 4. 6 M, HDAC8: 1. 9 M, HDAC10: 7. 7 M). Product information CAS Number: 2196203 96 8 Molecular Weight: 256. 30 Formula: C15H16N2O2 Chemical Name: 3 (benzylamino) N hydroxy 4 methylbenzamide Smiles: CC1C=CC(=CC=1NCC1=CC=CC=C1)C(=O)NO InChiKey: